Novartis has been focused on protecting inventions in Japan(JP) with 109 publications in Q3 2023
The Japan(JP) Patent Office dominates the patent filings and grants with nearly 21% filings and 18% grants. The Japan(JP), European Patent Office (E/P), United States(US), and China(CN) patent Office are among the top ten patent offices where Novartis is filings its patents. Among the top granted patent authorities, Novartis has 19% of its grants in United States(US), 18% in Japan(JP), and 10% in Canada(CA).
Amgen could be the strongest competitor for Novartis
In terms of grant share, Novartis stands in two position among its competitors. Amgen and johnson & johnson secured the top positions according to recent patent publication data.
Patents related to rare diseases and climate change lead Novartis’s portfolio
Novartis has the highest number of patents in rare diseases followed by, climate change and healthtech. For rare diseases, nearly 31% of patents were filed and 29% of patents were granted in Q3 2023.
Ophthalmic devices related patents lead Novartis portfolio followed by leukemia, and multiple sclerosis
Novartis has highest number of patents in ophthalmic devices followed by leukemia, multiple sclerosis, chronic obstructive pulmonary disease (copd) and asthma. For ophthalmic devices, nearly 4% of patents were filed and 5% of patents were granted in Q3 2023.
For comprehensive analysis of Novartis‘s filings and grants, buy the databook here.
From 
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.